Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-015730
Filing Date
2024-11-14
Accepted
2024-11-14 16:30:29
Documents
59
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q capr-20240930x10q.htm   iXBRL 10-Q 1714125
2 EX-10.1 capr-20240930xex10d1.htm EX-10.1 33139
3 EX-10.6 capr-20240930xex10d6.htm EX-10.6 14682
4 EX-31.1 capr-20240930xex31d1.htm EX-31.1 10577
5 EX-31.2 capr-20240930xex31d2.htm EX-31.2 10312
6 EX-32.1 capr-20240930xex32d1.htm EX-32.1 5843
7 EX-32.2 capr-20240930xex32d2.htm EX-32.2 5831
  Complete submission text file 0001558370-24-015730.txt   6401336

Data Files

Seq Description Document Type Size
8 EX-101.SCH capr-20240930.xsd EX-101.SCH 48720
9 EX-101.CAL capr-20240930_cal.xml EX-101.CAL 37478
10 EX-101.DEF capr-20240930_def.xml EX-101.DEF 204304
11 EX-101.LAB capr-20240930_lab.xml EX-101.LAB 358729
12 EX-101.PRE capr-20240930_pre.xml EX-101.PRE 300719
62 EXTRACTED XBRL INSTANCE DOCUMENT capr-20240930x10q_htm.xml XML 905172
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34058 | Film No.: 241463121
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)